No Data
No Data
TherapeuticsMD Full Year 2024 Earnings: US$0.20 Loss per Share (Vs US$0.74 Loss in FY 2023)
TherapeuticsMD Reports Reduced Losses and Revenue Growth
Therapeutics MD GAAP EPS of -$0.20
TherapeuticsMD | 10-K: FY2024 Annual Report
Express News | TherapeuticsMD FY24 EPS ($0.20) Up From ($0.74) YoY; Revenue $1.8M Up From $1.3M YoY
Press Release: TherapeuticsMD Announces Full Year 2024 Financial Results